Ameritas Investment Partners, Inc. - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 98 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$116,161
+66.1%
5,067
+19.4%
0.01%
+66.7%
Q2 2023$69,951
+74.9%
4,242
+22.8%
0.00%
+200.0%
Q1 2022$40,000
+17.6%
3,4540.0%0.00%0.0%
Q4 2021$34,000
-24.4%
3,4540.0%0.00%
-50.0%
Q3 2021$45,000
-33.8%
3,4540.0%0.00%0.0%
Q2 2021$68,000
+7.9%
3,454
+16.3%
0.00%0.0%
Q1 2021$63,000
-28.4%
2,9700.0%0.00%
-50.0%
Q4 2020$88,000
+37.5%
2,9700.0%0.00%
+33.3%
Q3 2020$64,000
-3.0%
2,9700.0%0.00%0.0%
Q2 2020$66,000
+73.7%
2,970
+18.1%
0.00%
+50.0%
Q1 2020$38,000
-34.5%
2,5150.0%0.00%
-33.3%
Q4 2019$58,000
+34.9%
2,515
+26.6%
0.00%
+50.0%
Q3 2019$43,000
-2.3%
1,9860.0%0.00%0.0%
Q2 2019$44,000
+57.1%
1,986
+95.5%
0.00%
+100.0%
Q1 2019$28,000
+3.7%
1,0160.0%0.00%0.0%
Q4 2018$27,000
-10.0%
1,0160.0%0.00%0.0%
Q3 2018$30,000
-6.2%
1,0160.0%0.00%
-50.0%
Q2 2018$32,000
+128.6%
1,016
+45.1%
0.00%
+100.0%
Q1 2018$14,000
-30.0%
7000.0%0.00%0.0%
Q4 2017$20,0007000.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 810,000$19,845,0008.20%
NEA Management Company, LLC 4,912,306$108,316,0005.41%
Frazier Life Sciences Management, L.P. 1,894,000$46,403,0003.57%
RA Capital Management 5,471,067$134,041,0002.86%
Samsara BioCapital, LLC 345,293$8,460,0001.97%
Altium Capital Management LP 170,000$4,165,0001.53%
Parkman Healthcare Partners LLC 187,989$4,606,0001.31%
Rock Springs Capital Management LP 1,760,865$43,141,0001.11%
EAM Investors, LLC 198,699$4,868,0001.06%
Prosight Management, LP 80,000$1,960,0001.05%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders